Oncology Institute Debt/Equity Ratio 2020-2025 | TOI

Oncology Institute debt/equity ratio from 2020 to 2025. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.

Oncology Institute Debt/Equity Ratio 2020-2025 | TOI

Oncology Institute debt/equity ratio from 2020 to 2025. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$147.1B
CVS Health (CVS)$76.8B
Elevance Health (ELV)$65.1B
Cencora (COR)$56.3B
DiDi Global (DIDIY)$25.7B
Labcorp Holdings (LH)$22.2B
Natera (NTRA)$19B
BioMerieux (BMXMF)$17.7B
EUROFINS SCIENT (ERFSF)$15.9B
ICON (ICLR)$15.1B
CochLear (CHEOY)$13.4B
Solventum (SOLV)$12.9B
Medpace Holdings (MEDP)$12.6B
Revvity (RVTY)$12.2B
Viatris (VTRS)$11B
Avantor (AVTR)$9.7B
Sonic Healthcare (SKHHY)$9.1B
Charles River Laboratories (CRL)$8.7B
HealthEquity (HQY)$8.3B
Caris Life Sciences,�Inc (CAI)$7.5B
Amplifon S.p.A (AMFPF)$5.4B
Bausch + Lomb (BLCO)$5.1B
BrightSpring Health Services (BTSG)$3.6B
Sotera Health (SHC)$3.5B
Surgery Partners (SGRY)$2.7B
Organon (OGN)$2.7B
Concentras Parent (CON)$2.5B
Alignment Healthcare (ALHC)$2.3B
GeneDx Holdings (WGS)$2.3B
Progyny (PGNY)$2B